Harnessing Hazara Virus as a Surrogate for Crimean–Congo Hemorrhagic Fever Virus Enables Inactivation Studies at a Low Biosafety Level
Research on highly pathogenic biosafety level 4 (BSL-4) viruses that are classified as Select Agents involves transferring inactivated materials to lower containment levels for further analysis. Compliance with Select Agent and BSL-4 safety regulations necessitates the validation and verification of...
Saved in:
| Main Authors: | Judith Olejnik, Kristina Meier, Jarod N. Herrera, Daniel J. DeStasio, Dylan J. Deeney, Elizabeth Y. Flores, Mitchell R. White, Adam J. Hume, Elke Mühlberger |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-07-01
|
| Series: | Pathogens |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-0817/14/7/700 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Persistent Infections in Tick Cell Lines: The Role of Viral-Derived DNA Forms in Hazara Virus Replication and Cellular Survival
by: Eva Dias, et al.
Published: (2025-04-01) -
Crimean-Congo Hemorrhagic Fever Virus among Goats, Southern Bhutan
by: Sangay Rinchen, et al.
Published: (2025-08-01) -
Crimean-Congo Hemorrhagic Fever Virus Africa 1 Lineage in Hyalomma dromedarii Ticks, Algeria, 2023
by: Marbouha Temani, et al.
Published: (2025-08-01) -
N6-methyladenosine is required for efficient RNA synthesis of Ebola virus and other haemorrhagic fever viruses
by: Lisa Wendt, et al.
Published: (2023-12-01) -
Prime-Boost Vaccination Based on Nanospheres and MVA Encoding the Nucleoprotein of Crimean-Congo Hemorrhagic Fever Virus Elicits Broad Immune Responses
by: Eva Calvo-Pinilla, et al.
Published: (2025-03-01)